These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32429117)
1. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity. Lee CH; Lee DH; Lee SM; Kim ASY Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429117 [TBL] [Abstract][Full Text] [Related]
2. Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss. Lee CH; Kim KW; Lee SM; Kim SY Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374326 [TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats. Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715 [TBL] [Abstract][Full Text] [Related]
4. Effects of Androgen Receptor Inhibition on Kanamycin-Induced Hearing Loss in Rats. Chun KJ; Lee CH; Kim KW; Lee SM; Kim SY Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34070066 [TBL] [Abstract][Full Text] [Related]
5. Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats. Lee CH; Lee SM; Kim SY Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884516 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of zingerone on oxidative stress and inflammation in cisplatin-induced rat nephrotoxicity. Alibakhshi T; Khodayar MJ; Khorsandi L; Rashno M; Zeidooni L Biomed Pharmacother; 2018 Sep; 105():225-232. PubMed ID: 29857302 [TBL] [Abstract][Full Text] [Related]
7. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea. Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy. Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784 [TBL] [Abstract][Full Text] [Related]
9. Zingerone ameliorates cisplatin-induced ovarian and uterine toxicity via suppression of sex hormone imbalances, oxidative stress, inflammation and apoptosis in female wistar rats. Kaygusuzoglu E; Caglayan C; Kandemir FM; Yıldırım S; Kucukler S; Kılınc MA; Saglam YS Biomed Pharmacother; 2018 Jun; 102():517-530. PubMed ID: 29587238 [TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model. García-Berrocal JR; Nevado J; González-García JA; Sánchez-Rodríguez C; Sanz R; Trinidad A; España P; Citores MJ; Ramírez-Camacho R J Laryngol Otol; 2010 Jun; 124(6):599-609. PubMed ID: 20307356 [TBL] [Abstract][Full Text] [Related]
11. GSTA4 mediates reduction of cisplatin ototoxicity in female mice. Park HJ; Kim MJ; Rothenberger C; Kumar A; Sampson EM; Ding D; Han C; White K; Boyd K; Manohar S; Kim YH; Ticsa MS; Gomez AS; Caicedo I; Bose U; Linser PJ; Miyakawa T; Tanokura M; Foster TC; Salvi R; Someya S Nat Commun; 2019 Sep; 10(1):4150. PubMed ID: 31515474 [TBL] [Abstract][Full Text] [Related]
12. Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model. Giordano P; Lorito G; Ciorba A; Martini A; Hatzopoulos S Acta Otorhinolaryngol Ital; 2006 Aug; 26(4):198-207. PubMed ID: 18236636 [TBL] [Abstract][Full Text] [Related]
13. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model. Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472 [TBL] [Abstract][Full Text] [Related]
14. Effect of Folic Acid on Cisplatin-Induced Ototoxicity: A Functional and Morphological Study. Tanyeli TT; Karadaş H; Akyıldız İ; Gökdoğan O; Sönmez Ç; Çavuş ME; Kaptan Z; Uzunkulaoğlu H; Arslan N; Zeybek ND J Int Adv Otol; 2019 Aug; 15(2):237-246. PubMed ID: 31347504 [TBL] [Abstract][Full Text] [Related]
15. Are There Cochlear Dead Regions Involved in Hearing Loss after Cisplatin Ototoxicity? Schultz C; Pecora Liberman PH; Schmidt Goffi-Gomez MV Audiol Neurootol; 2019; 24(5):253-257. PubMed ID: 31661686 [TBL] [Abstract][Full Text] [Related]
17. Circadian vulnerability of cisplatin-induced ototoxicity in the cochlea. Tserga E; Moreno-Paublete R; Sarlus H; Björn E; Guimaraes E; Göritz C; Cederroth CR; Canlon B FASEB J; 2020 Oct; 34(10):13978-13992. PubMed ID: 32840016 [TBL] [Abstract][Full Text] [Related]
18. Epicatechin protects the auditory organ by attenuating cisplatin-induced ototoxicity through inhibition of ERK. Lee JS; Kang SU; Hwang HS; Pyun JH; Choung YH; Kim CH Toxicol Lett; 2010 Dec; 199(3):308-16. PubMed ID: 20883750 [TBL] [Abstract][Full Text] [Related]
19. The ototoxicity of 3,3'-iminodipropionitrile: functional and morphological evidence of cochlear damage. Crofton KM; Janssen R; Prazma J; Pulver S; Barone S Hear Res; 1994 Nov; 80(2):129-40. PubMed ID: 7896571 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney. Kandemir FM; Yildirim S; Kucukler S; Caglayan C; Mahamadu A; Dortbudak MB Biomed Pharmacother; 2018 Sep; 105():981-991. PubMed ID: 30021393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]